×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NSPR – inspiremd inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NSPR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/24
07:30 am
nspr
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
Low
Report
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
11/21
10:25 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
11/21
09:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/19
04:41 pm
nspr
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
High
Report
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
11/4
07:00 am
nspr
InspireMD Reports Third Quarter 2025 Financial Results
Medium
Report
InspireMD Reports Third Quarter 2025 Financial Results
11/3
07:30 am
nspr
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
Medium
Report
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
10/21
04:05 pm
nspr
InspireMD to Announce Third Quarter 2025 Financial Results
Medium
Report
InspireMD to Announce Third Quarter 2025 Financial Results
10/8
08:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/5
04:05 pm
nspr
Form 4 InspireMD, Inc. For: Dec 04 Filed by: Stuka Paul
Neutral
Report
Form 4 InspireMD, Inc. For: Dec 04 Filed by: Stuka Paul
11/14
06:12 pm
nspr
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
11/14
04:53 pm
nspr
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Nantahala Capital Management, LLC
11/14
04:37 pm
nspr
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Nantahala Capital Partners Limited Partnership
Medium
Report
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: Nantahala Capital Partners Limited Partnership
11/14
04:29 pm
nspr
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: MARSHALL WACE, LLP
Medium
Report
Form SCHEDULE 13G/A InspireMD, Inc. Filed by: MARSHALL WACE, LLP
11/14
12:44 pm
nspr
Form SCHEDULE 13G InspireMD, Inc. Filed by: Parkman Healthcare Partners LLC
Low
Report
Form SCHEDULE 13G InspireMD, Inc. Filed by: Parkman Healthcare Partners LLC
11/10
04:06 pm
nspr
Form 10-Q InspireMD, Inc. For: Sep 30
Low
Report
Form 10-Q InspireMD, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/28
Form 8-K InspireMD, Inc. For: Jan 27
15.6%
9/9 Form 8-K InspireMD, Inc. For: Sep 09 12.5%
2/5 Form SC 13G/A InspireMD, Inc. Filed by: BIGGER CAPITAL FUND L P 12.4%
11/26 InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019 9.4%
7/30 InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6 7.5%
4/3 Form 8-K InspireMD, Inc. For: Apr 03 6.7%
9/27 Form SC 13G InspireMD, Inc. Filed by: ARMISTICE CAPITAL, LLC 4.8%
8/9 InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency 4.2%
3/3 InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10 2.6%
11/5 InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12 2.4%
9/9 Form 8-K InspireMD, Inc. For: Sep 09 12.5%
2/5 Form SC 13G/A InspireMD, Inc. Filed by: BIGGER CAPITAL FUND L P 12.4%
11/26 InspireMD Reports Updated Positive CGuard™ EPS Data Presented at VEITH 2019 9.4%
7/30 InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6 7.5%
4/3 Form 8-K InspireMD, Inc. For: Apr 03 6.7%
9/27 Form SC 13G InspireMD, Inc. Filed by: ARMISTICE CAPITAL, LLC 4.8%
8/9 InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency 4.2%
3/3 InspireMD to Report Fourth Quarter 2019 Financial Results and Provide Business Update on Tuesday, March 10 2.6%
11/5 InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12 2.4%
TOP News Decliners
9/19
InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering
-44.0%
3/10 Form 10-K InspireMD, Inc. For: Dec 31 -34.4%
5/14 InspireMD Announces First Quarter 2019 Financial Results -22.4%
11/12 UPDATE: InspireMD Announces Third Quarter 2019 Financial Results -21.6%
8/23 Form S-1 InspireMD, Inc. -17.9%
8/5 Form 10-Q InspireMD, Inc. For: Jun 30 -15.0%
1/29 InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2020 -14.7%
1/6 Form 8-K InspireMD, Inc. For: Dec 31 -12.5%
11/12 InspireMD (NSPR) Investor Presentation - Slideshow [Seeking Alpha] -6.7%
1/27 InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany -6.3%
3/10 Form 10-K InspireMD, Inc. For: Dec 31 -34.4%
5/14 InspireMD Announces First Quarter 2019 Financial Results -22.4%
11/12 UPDATE: InspireMD Announces Third Quarter 2019 Financial Results -21.6%
8/23 Form S-1 InspireMD, Inc. -17.9%
8/5 Form 10-Q InspireMD, Inc. For: Jun 30 -15.0%
1/29 InspireMD Announces Successful Live Clinical Case Transmissions Featuring CGuard™ EPS at the Leipzig Interventional Course (LINC) 2020 -14.7%
1/6 Form 8-K InspireMD, Inc. For: Dec 31 -12.5%
11/12 InspireMD (NSPR) Investor Presentation - Slideshow [Seeking Alpha] -6.7%
1/27 InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmission at LINC, 28th to the 31st January 2020, in Leipzig, Germany -6.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: